Farmabios manufactures and markets active ingredients for pharmaceutical applications (API, Active Pharmaceutical Ingredients):
Sterile semi-synthetic cephalosporins
HPS - Highly Potent Substances
Production of Antineoplastic
The company markets its products worldwide, with over 80% of its sales being in the major markets: European Union United States and Canada Japan
Thanks to a wide range of advanced proprietary technologies, Farmabios also provides custom synthesis services for the development and the commercial manufacturing of New Chemical Entities (NCEs) and proprietary Commercial APIs.
Farmabios has been in business since 1961 and currently employees 150 people in facilities spanning an area of 60-thousand square meters, 22-thousands of which have been set aside for plants.
The company is ISO 9001 and ISO 14001 certified. Farmabios operates in accordance with cGMP standards and is subjected to regular inspections by international bodies such as the FDA and the EDQM.
Through its in-house research and development department, the company is also able to offer specialist collaboration in terms of setting up specific production methods based on a wide range of technologies.
Farmabios has just recently finished implementing a development program, also involving a number of other partners, for the creation of a GMP plant capable of producing nanoparticles with dimensions of up to 50 nanometres, which allow for the improvement and enhancement of the characteristics of our APIs.
Our technicians are available to assist with studies involving powders with the best inherent characteristics for the specific applications that are of interest to the customer.